Report Detail

Request for Sample of this report

Other Global Fabry Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3787037
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Fabry Disease Treatment market size was valued at USD 1576.6 million in 2023 and is forecast to a readjusted size of USD 2243.3 million by 2030 with a CAGR of 5.2% during review period.
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Fabry Disease Treatment industry chain, the market status of Hospital (Enzyme Replacement Therapy (ERT), Chaperone Treatment), Clinic (Enzyme Replacement Therapy (ERT), Chaperone Treatment), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Fabry Disease Treatment.
Regionally, the report analyzes the Fabry Disease Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Fabry Disease Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Fabry Disease Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Fabry Disease Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Enzyme Replacement Therapy (ERT), Chaperone Treatment).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Fabry Disease Treatment market.
Regional Analysis: The report involves examining the Fabry Disease Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Fabry Disease Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Fabry Disease Treatment:
Company Analysis: Report covers individual Fabry Disease Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Fabry Disease Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Fabry Disease Treatment. It assesses the current state, advancements, and potential future developments in Fabry Disease Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Fabry Disease Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Fabry Disease Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Fabry Disease Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Fabry Disease Treatment, with revenue, gross margin and global market share of Fabry Disease Treatment from 2019 to 2024.
Chapter 3, the Fabry Disease Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Fabry Disease Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fabry Disease Treatment.
Chapter 13, to describe Fabry Disease Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Fabry Disease Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Fabry Disease Treatment by Type
    • 1.3.1 Overview: Global Fabry Disease Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Fabry Disease Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Enzyme Replacement Therapy (ERT)
    • 1.3.4 Chaperone Treatment
    • 1.3.5 Substrate Reduction Therapy (SRT)
    • 1.3.6 Others
  • 1.4 Global Fabry Disease Treatment Market by Application
    • 1.4.1 Overview: Global Fabry Disease Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Fabry Disease Treatment Market Size & Forecast
  • 1.6 Global Fabry Disease Treatment Market Size and Forecast by Region
    • 1.6.1 Global Fabry Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Fabry Disease Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Fabry Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Fabry Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Fabry Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Fabry Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Fabry Disease Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Sanofi S.A.
    • 2.1.1 Sanofi S.A. Details
    • 2.1.2 Sanofi S.A. Major Business
    • 2.1.3 Sanofi S.A. Fabry Disease Treatment Product and Solutions
    • 2.1.4 Sanofi S.A. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi S.A. Recent Developments and Future Plans
  • 2.2 Takeda
    • 2.2.1 Takeda Details
    • 2.2.2 Takeda Major Business
    • 2.2.3 Takeda Fabry Disease Treatment Product and Solutions
    • 2.2.4 Takeda Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Takeda Recent Developments and Future Plans
  • 2.3 Amicus Therapeutics Inc.
    • 2.3.1 Amicus Therapeutics Inc. Details
    • 2.3.2 Amicus Therapeutics Inc. Major Business
    • 2.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Product and Solutions
    • 2.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Amicus Therapeutics Inc. Recent Developments and Future Plans
  • 2.4 ISU Abxis Co Ltd.
    • 2.4.1 ISU Abxis Co Ltd. Details
    • 2.4.2 ISU Abxis Co Ltd. Major Business
    • 2.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Product and Solutions
    • 2.4.4 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 ISU Abxis Co Ltd. Recent Developments and Future Plans
  • 2.5 JCR Pharmaceuticals Co Ltd.
    • 2.5.1 JCR Pharmaceuticals Co Ltd. Details
    • 2.5.2 JCR Pharmaceuticals Co Ltd. Major Business
    • 2.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product and Solutions
    • 2.5.4 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 JCR Pharmaceuticals Co Ltd. Recent Developments and Future Plans
  • 2.6 Protalix Biotherapeutics Inc.
    • 2.6.1 Protalix Biotherapeutics Inc. Details
    • 2.6.2 Protalix Biotherapeutics Inc. Major Business
    • 2.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Product and Solutions
    • 2.6.4 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Protalix Biotherapeutics Inc. Recent Developments and Future Plans
  • 2.7 Idorsia Pharmaceuticals Ltd.
    • 2.7.1 Idorsia Pharmaceuticals Ltd. Details
    • 2.7.2 Idorsia Pharmaceuticals Ltd. Major Business
    • 2.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product and Solutions
    • 2.7.4 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Idorsia Pharmaceuticals Ltd. Recent Developments and Future Plans
  • 2.8 Avrobio Inc.
    • 2.8.1 Avrobio Inc. Details
    • 2.8.2 Avrobio Inc. Major Business
    • 2.8.3 Avrobio Inc. Fabry Disease Treatment Product and Solutions
    • 2.8.4 Avrobio Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Avrobio Inc. Recent Developments and Future Plans
  • 2.9 Greenovation Biotech GmbH
    • 2.9.1 Greenovation Biotech GmbH Details
    • 2.9.2 Greenovation Biotech GmbH Major Business
    • 2.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Product and Solutions
    • 2.9.4 Greenovation Biotech GmbH Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Greenovation Biotech GmbH Recent Developments and Future Plans
  • 2.10 Moderna Therapeutics Inc.
    • 2.10.1 Moderna Therapeutics Inc. Details
    • 2.10.2 Moderna Therapeutics Inc. Major Business
    • 2.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Product and Solutions
    • 2.10.4 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Moderna Therapeutics Inc. Recent Developments and Future Plans
  • 2.11 Green Cross Pharma Pte Ltd.
    • 2.11.1 Green Cross Pharma Pte Ltd. Details
    • 2.11.2 Green Cross Pharma Pte Ltd. Major Business
    • 2.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product and Solutions
    • 2.11.4 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Green Cross Pharma Pte Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Fabry Disease Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Fabry Disease Treatment by Company Revenue
    • 3.2.2 Top 3 Fabry Disease Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Fabry Disease Treatment Players Market Share in 2023
  • 3.3 Fabry Disease Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Fabry Disease Treatment Market: Region Footprint
    • 3.3.2 Fabry Disease Treatment Market: Company Product Type Footprint
    • 3.3.3 Fabry Disease Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Fabry Disease Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Fabry Disease Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Fabry Disease Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Fabry Disease Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Fabry Disease Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Fabry Disease Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Fabry Disease Treatment Market Size by Country
    • 6.3.1 North America Fabry Disease Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Fabry Disease Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Fabry Disease Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Fabry Disease Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Fabry Disease Treatment Market Size by Country
    • 7.3.1 Europe Fabry Disease Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Fabry Disease Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Fabry Disease Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Fabry Disease Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Fabry Disease Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Fabry Disease Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Fabry Disease Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Fabry Disease Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Fabry Disease Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Fabry Disease Treatment Market Size by Country
    • 9.3.1 South America Fabry Disease Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Fabry Disease Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Fabry Disease Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Fabry Disease Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Fabry Disease Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Fabry Disease Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Fabry Disease Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Fabry Disease Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Fabry Disease Treatment Market Drivers
  • 11.2 Fabry Disease Treatment Market Restraints
  • 11.3 Fabry Disease Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Fabry Disease Treatment Industry Chain
  • 12.2 Fabry Disease Treatment Upstream Analysis
  • 12.3 Fabry Disease Treatment Midstream Analysis
  • 12.4 Fabry Disease Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Fabry Disease Treatment. Industry analysis & Market Report on Fabry Disease Treatment is a syndicated market report, published as Global Fabry Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Fabry Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo